Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP13-672B3.2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | HSPE1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | SNIP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | TUBA1C | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | RPRM | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | SLX4IP | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ZNF547 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | RBM12B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | PYGO2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | KIF27 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |